We have become aware of an individual who is falsely representing themselves as a member of the Celerion HR team. Please be cautious when responding to any communication that purports to come from Celerion. All email communication from Celerion will come from an email address appended @celerion.com. No other addresses are legitimate. #hr
Celerion
Pharmaceutical Manufacturing
Lincoln, NE 15,795 followers
Celerion Can Take You from First-In-Human through Proof-of-Concept.
About us
Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines. With over 50 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings. Our operations are strategically located in: Lincoln, Nebraska (Corporate Headquarters) Philadelphia, Pennsylvania Phoenix, Arizona Belfast, Northern Ireland,UK Zurich, Switzerland Vienna, Austria Richmond, Virginia Montreal, Quebec, Canada For more information, visit: www.celerion.com
- Website
-
http://www.celerion.com
External link for Celerion
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Lincoln, NE
- Type
- Privately Held
- Founded
- 2010
- Specialties
- Applied Translational Medicine, Global Clinical Research (Phase I and II, NDA-enabling clinical pharmacology), Data Management and Biometrics, Global Bioanalytical Services (discovery through late phase), Drug Development Services, and Global Clinical Development
Locations
Employees at Celerion
Updates
-
Photosafety testing is recommended for systemic and transdermal drugs that absorb light within the natural sunlight range. A solar simulator is used to generate UVA/B wavebands that are exposed to the skin at baseline and post-drug administration. Then, erythema and irritation assessments are performed to evaluate phototoxicity and photoallergy adverse events. Check out our recent poster showcasing a photosafety study design: https://lnkd.in/exiibZSp #photosafety #UVA #UVB #phototoxicity #photoallergy
-
Celerion is more than a service provider; we're your trusted partner in bringing next-level breakthroughs to life. Our unique combination of medical expertise, clinical operations experience, and scientific excellence enables you to make timely decisions with expert advice and high-quality data. Learn More: https://lnkd.in/epnrcyEx #LifeChangingScience #AdvancedBioanalysis #DrugDiscovery
-
Early-phase clinical pharmacology studies with healthy volunteers provide the opportunity to collect robust PK data, speed up study timelines, and reduce costs. Learn about all the advantages this approach can offer to accelerate oncology small molecule drug development. Read our blog: https://lnkd.in/eZj6ET6k Also, check out our Product Labeling Fact Sheet: https://lnkd.in/gNAaFqXY #DrugDevelopment #HealthyVolunteers #CancerTreatment
-
Celexus® is Celerion’s reporting tool that delivers real-time access to operational key performance indicators, a centralized repository for study documentation, and a dynamically interactive experience for analyzing and interpreting clinical data. Learn more: https://lnkd.in/dfxHmDA #HappyHalloween #ClinicalData #DrugDevelopment #Automation
-
Celerion has a strong track record of clinical studies supporting the development of our clients' drugs, many of which have obtained regulatory approval. Our mission is to focus every day on helping our clients get their drugs to market so that they touch the lives of our family, friends, and people in need around the world. Learn more: www.celerion.com #HappyHalloween #ClinicalSuccess #DrugDevelopment
-
In our tutorial: “Should You Run a Dedicated TQT Study? Sponsor and Regulatory Considerations on Substitution Pathways to Assess QT Liability”, we listed out reasons why a TQT substitution or ‘waiver’ can be denied. Read the tutorial to avoid these common pitfalls. Read the CPT tutorial: https://lnkd.in/eeaVxPvT #TQTwaiver #TQTsubstitution #ECGcorelab #CPTJournal #ASCPTJournalFamily
-
Once a study is awarded, we can be ready in a matter of weeks to start participant dosing. We built efficiencies into our start-up processes, have the capacity to conduct multiple ADME studies at once and have the expertise to execute them. Our dedicated team of ADME specialists, including our on-site Nuclear Pharmacist, have conducted more than 100 radiolabeled clinical studies. Read more: https://lnkd.in/e8Hk8bdE #ADMEExperts #ClinicalStudies #MultiStudyCapacity #ClinicalInnovation
-
LC-MS/MS is a mature technology in Bioanalysis and is often called a commodity. This may be true as it is available in many laboratories around the world. However, with today’s complex new modalities, highly challenging small molecules, peptides, and oligonucleotides, the challenges in developing LC-MS/MS assays are greater than ever. At Celerion, we’ve been doing LC-MS/MS analysis in our laboratories since 1992. We have a long history of innovations and experience with challenging projects. For instance, we have performed bioanalysis of peptides and oligonucleotides for over 20 years. The complex small molecules such as protein degraders and biomarkers often require close collaboration with our on-site clinics for proper sample collection or our LBA and Flow Cytometry teams for associated biomarker analysis. In the case of ADC’s you get all of your complex bioanalysis under one roof with one set of management. Even the traditional small molecules are smaller, stickier, less stable, and nonpolar. All challenges that a lab with experience must address. Learn more about Celerion's Bioanalytical Services: https://lnkd.in/e94Jchx #Bioanalysis #LCMSMS #Peptides #Oligonucleotides #SmallMolecules #DrugDevelopment #PharmaResearch
-
Happy National Pharmacy Week! At Celerion, our pharmacy team plays a crucial role in advancing clinical research and improving patient outcomes. Your dedication, expertise, and hard work behind the scenes ensure that our studies run smoothly and safely. Thank you for your commitment to excellence, your attention to detail, and your tireless efforts to make a difference in the lives of so many. We appreciate all that you do today and every day! Learn more about Celerion: https://celerion.com https://lnkd.in/d9nMNTQ #NationalPharmacyWeek #ThankYouPharmacists #ClinicalResearch